IP Library Granted Patent US 9,315,797
Granted Patent B2
US 9,315,797 · App. 14/510,494 · Granted Apr 19, 2016

Solubilized phospholipids for stabilizing nucleic acid polymerases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,315,797
App. No.
14/510,494
Granted
Apr 19, 2016
Kind
B2
Abstract

Compositions and methods are provided that relate to solubilized phospholipids and their use in stabilizing nucleic acid polymerases. For example, a phospholipid with a tail containing at least 8 carbons can be solubilized in the presence of an amphipathic molecule.

Claims (32)

1. A composition comprising:

(a) a thermostable polymerase; and

(b) a solubilized phospholipid comprising at least one hydrophobic tail containing 8 to 30 carbons.

2. The composition of claim 1 , wherein the phospholipid is a phosphatidyl lipid.

3. The composition of claim 2 , wherein the phospholipid is a phosphatidylcholine.

4. The composition of claim 1 , wherein the phospholipid is an ether lipid.

5. The composition of claim 1 , wherein the phospholipid is a sphingolipid.

6. The composition of claim 1 , wherein the phospholipid is a diacyl phospholipid.

7. The composition of claim 1 , wherein the phospholipid comprises a plasminogen core.

8. The composition of claim 1 , wherein, in the composition, the phospholipid is solubilized by an amphipathic solubilizer.

9. The composition of claim 8 , wherein the amphipathic solubilizer is a lipid having a hydrophobic tail containing no more than 8 carbons.

10. The composition of claim 1 , wherein the thermostable polymerase is a bacterial polymerase.

11. The composition of claim 1 , wherein the thermostable polymerase is an archael polymerase.

12. The composition of claim 1 , wherein the thermostable polymerase is Taq polymerase or a variant thereof.

13. The composition of claim 1 , further comprising a buffering agent.

14. The composition of claim 13 , wherein the buffering agent is Tris.

15. The composition of claim 1 , further comprising glycerol.

16. The composition of claim 1 , further comprising dNTPs.

17. The composition of claim 1 , wherein the composition comprises a solubilizer and the long-chain phospholipid at a molar ratio in the range of 1:1 to 10:1.

18. A kit comprising:

a thermostable polymerase;

a phospholipid having at least one hydrophobic tail containing 8 to 30 carbons; and

a solubilizer that solubilizes the phospholipid.

19. The kit of claim 18 , wherein the thermostable polymerase, phospholipid and solubilizer are in the same tube.

20. The kit of claim 18 , wherein the thermostable polymerase is in a different tube to the phospholipid and solubilizer.

21. The kit of claim 18 , wherein the phospholipid is a phosphatidyl lipid, a phosphatidylcholine, an ether lipid, a sphingolipid or a diacyl phospholipid, or comprises a plasminogen core.

22. The kit of claim 18 , wherein the stabilizer is a lipid having a hydrophobic tail containing no more than 8 carbons.

23. The kit of claim 18 , wherein the thermostable polymerase is a bacterial polymerase.

24. The kit of claim 18 , wherein the thermostable polymerase is an archael polymerase.

25. The kit of claim 18 , wherein the thermostable polymerase is Taq polymerase or a variant thereof.

26. The kit of claim 18 , further comprising a concentrated reaction buffer.

27. The kit of claim 18 , further comprising dNTPs.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2016
From: JOHNSON, DONALD; EVANS, THOMAS C., JR.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 037985/0182 →